Microfibrous extracellular matrix enhances in vitro modeling of the liver hepatocytes by modulating metabolism and integrin expression

Author/Creator ORCID

Date

2020-01

Department

Program

Citation of Original Publication

Tianjiao Huang, Curtis G. Jones, Jay H. Chung, and Chengpeng Chen, Microfibrous Extracellular Matrix Changes the Liver Hepatocyte Energy Metabolism via Integrins, ACS Biomaterials Science & Engineering 2020 6 (10), 5849-5856 DOI: 10.1021/acsbiomaterials.0c01311

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
This document is the unedited Author’s version of a Submitted Work that was subsequently accepted for publication in ACS Biomater. Sci. Eng, copyright © American Chemical Society after peer review. To access the final edited and published work see https://doi.org/10.1021/acsbiomaterials.0c01311.

Subjects

Abstract

2 Introduction The liver carries out a number of essential functions, including blood detoxification, protein synthesis, regulation of energy balance, and production of other biochemicals to maintain the whole-body homeostasis1. In addition to these physiological functions, the liver is also the main site of drug metabolism, making it vulnerable to drug toxicity; indeed, hepatotoxicity is one of the leading causes for drug failure2. Thus, detecting the potential for hepatotoxicity of a drug at the early stage of drug development/screening will minimize the failure rate and, therefore, the cost of bringing a drug into the market. Therefore, hepatic models are invaluable tools in drug discovery and development